Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KANABO GROUP PLC Director's Dealing 2023

Jun 23, 2023

4978_dirs_2023-06-23_f095966e-c19d-4b7a-86a2-d2943418bd7d.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6602D

Kanabo Group PLC

23 June 2023

23 June 2023

Kanabo Group Plc

("Kanabo" or the "Company")

Grant of Options

Kanabo Group Plc (LSE:KNB), the patient focused healthcare technology and medicinal cannabis company, announces that on 19 June 2023 it granted options over a total of 25,050,000 ordinary shares in the Company ("Shares") to certain employees, pursuant to their terms of employment (the "Awards").

The Awards were granted were granted to certain persons discharging managerial responsibilities ("PDMR") and other employees, and are summarised below:

Name No. of Options Vested options as of today Option Exercise Price Vesting Period for non-vested options
David Tsur

Deputy Chair
2,000,000 - 2.88p The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date.
Ian Mattioli

Chair
3,000,000 - 2.88p The options shall vest and become exercisable in four equal portions which shall vest over a 2-year period from the Vesting Start Date
Sharon Malka

Non-Executive Director
2,025000 - 2.88p The options shall vest and become exercisable in four equal portions which shall vest over a 2-year period from the Vesting Start Date.
Assaf Vardimon

CFO
2,500,000 - 2.88p The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date.
Suleman Sacranie

CPO/CTO *
11,000,000 5,500,004 2.88p The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date.
Other Employees 2,500,000 - 2.88p The options shall vest over a 3-year period. 33% vest at the end of the 12-month period following the Vesting Start Date. The remaining options vest over 8 equal 3-month periods thereafter.
Other Employees 2,025,000 - 2.88p The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date.

* Mr. Sacranie has agreed to surrender 5,829,400 Options granted on 31 August 2022 which carry exercise price of 6.5p and 8p.

For further information, please visit http://www.kanabogroup.com/ or contact the following:

Enquiries:

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Assaf Vardimon, Chief Financial Officer

Ian Mattioli, Non-Executive Chair of the Board
via Vigo Consulting

+44 (0)20 7390 0230
Peterhouse Capital Ltd (Financial Adviser and Broker)

Eran Zucker/ Lucy Williams / Charles Goodfellow
+44 (0)20 7469 0930
Vigo Consulting (Financial Public Relations/Investor Relations)

Jeremy Garcia / Fiona Hetherington / Verity Snow

[email protected]
+44 (0)20 7390 0230

About Kanabo Group Plc

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. The Company is a leader in its field, focusing on improving patient outcomes and providing more accessible healthcare experiences.

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com for more information.

The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name David Tsur
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Kanabo Group Plc
b) LEI 213800XPJFSNWJIYKN52
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
c) Price(s) and volume(s)
Price(s) Volume(s)
2.88p 2,000,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 19.6.2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ian Mattioli
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Kanabo Group Plc
b) LEI 213800XPJFSNWJIYKN52
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
c) Price(s) and volume(s)
Price(s) Volume(s)
2.88p 3,000,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 19.6.2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Sharon Malka
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Kanabo Group Plc
b) LEI 213800XPJFSNWJIYKN52
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
c) Price(s) and volume(s)
Price(s) Volume(s)
2.88p 2,025,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 19.6.2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Assaf Vardimon
2 Reason for the notification
a) Position/status CFO
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Kanabo Group Plc
b) LEI 213800XPJFSNWJIYKN52
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
c) Price(s) and volume(s)
Price(s) Volume(s)
2.88p 2,500,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 19.6.2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Suleman Sacranie
2 Reason for the notification
a) Position/status CPO/CTO
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Kanabo Group Plc
b) LEI 213800XPJFSNWJIYKN52
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00BYQCS703
b) Nature of the transaction Share Options
c) Price(s) and volume(s)
Price(s) Volume(s)
2.88p 11,000,000
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 19.6.2023
f) Place of the transaction London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCNKBBPFBKDFAB